EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Administration of anti-GFAP antibodies increases CGRP expression and increases pain hypersensitivity in spinal cord injured animals

Georgene W Hergenroeder iD, Samuel T Molina iD, Juan J Herrera iD

International Journal of Immunopathology and Pharmacology · 2025

DOI: 10.1177/03946320251320754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Immunopathology and Pharmacology, 2025. Verfasst von Georgene W Hergenroeder und 2 weiteren Autor:innen. Beteiligte Einrichtung: Vivian L. Smith Department of Neurosurgery, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, USA. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Glial Fibrillary Acidic Protein, Calcitonin Gene-Related Peptide, Neuralgia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Mission Connect, a program of TIRR Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Spinal cord injury (SCI) results in a multitude of cellular and pathological changes including neuronal loss, axonal damage, gliosis, and loss of motor and sensory function. In 40%–70% of patients, SCI can also trigger the development of neuropathic pain. Our previous study demonstrated that SCI patients who developed autoantibodies to glial fibrillary acidic protein (GFAP) were at increased risk for the subsequent development of neuropathic pain. However, whether GFAP autoantibodies (GFAPab) contribute to the development of neuropathic pain after SCI had yet to be examined.

Objective

Using a mid-thoracic contusion model of SCI in male Sprague-Dawley rats, we examined the effect of exogenous anti-GFAP antibodies on SCI pathology, pain-associated molecular changes, and behavior.

Methods

Anti-GFAP or IgG was administered at 7- and 14-days post-injury. Immunohistochemistry was performed to measure the relative levels of calcitonin gene-related peptide (CGRP), and inflammatory proteins in dorsal horn tissue. To assess the development of neuropathic pain, the von Frey test and the Mechanical Conflict-Avoidance Paradigm (MCAP) were performed.

Results

CGRP immunoreactivity was significantly higher in the anti-GFAP-treated injured rats compared to control SCI IgG-treated rats. As anticipated, SCI rats had a lower pain threshold at 1- and 2-months post-injury compared to laminectomy-only controls. However, pain withdrawal threshold was not significantly affected by post-injury administration of the anti-GFAP. Operant testing revealed that SCI rats treated with the anti-GFAP had a trending increase in pain sensitivity.

Conclusion

Taken together, these data suggest that autoantibodies to GFAP following SCI may contribute to developing pain states following SCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesGlial Fibrillary Acidic ProteinCalcitonin Gene-Related PeptideNeuralgiaAutoantibodiesHyperalgesiaAnimalsRats, Sprague-DawleyMaleRatsDisease Models, AnimalPain Threshold

Stichwörter der Autor:innen

autoantibodies/immunologycalcitonin gene-related peptideglial fibrillary acidic protein/immunologyneuralgia/etiologyspinal cord injuries/complications

Substanzen

Glial Fibrillary Acidic ProteinCalcitonin Gene-Related PeptideAutoantibodiesGfap protein, rat

Autor:innen und Institutionen

  • Vivian L. Smith Department of Neurosurgery, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Department of Diagnostic and Interventional Imaging, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, USA.

ORCID-Profile: Georgene W Hergenroeder, Samuel T Molina, Juan J Herrera

Förderung

  • Mission Connect, a program of TIRR Foundation

Zitieren

APA

Hergenroeder, G. W., Molina, S. T., & Herrera, J. J. (2025). Administration of anti-GFAP antibodies increases CGRP expression and increases pain hypersensitivity in spinal cord injured animals. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177/03946320251320754

Vancouver

Hergenroeder GW, Molina ST, Herrera JJ. Administration of anti-GFAP antibodies increases CGRP expression and increases pain hypersensitivity in spinal cord injured animals. International Journal of Immunopathology and Pharmacology. 2025. doi:10.1177/03946320251320754

BibTeX
@article{Hergenroeder2025,
  author = {Hergenroeder, Georgene W and Molina, Samuel T and Herrera, Juan J},
  title = {Administration of anti-GFAP antibodies increases CGRP expression and increases pain hypersensitivity in spinal cord injured animals},
  journal = {International Journal of Immunopathology and Pharmacology},
  year = {2025},
  doi = {10.1177/03946320251320754}
}
Kostenlos starten →